HLA-B Protein (AA 26-309) (His tag)
-
- Antigène Voir toutes HLA-B Protéines
- HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 26-309
- Origine
- Humain
-
Source
- Escherichia coli (E. coli)
- Purification/Conjugué
- Cette HLA-B protéine est marqué à la His tag.
- Application
- Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
- Séquence
- Ser26-Val309
- Attributs du produit
- Recombinant Major Histocompatibility Complex Class I B (MHCB), Prokaryotic expression, Ser26-Val309, N-terminal His Tag
- Pureté
- > 90 %
- Top Product
- Discover our top product HLA-B Protéine
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Isoelectric Point:5.9
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-80 °C
- Stockage commentaire
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
- Autre désignation
- Major Histocompatibility Complex Class I B (HLA-B Produits)
- Synonymes
- AS Protein, HLAB Protein, SPDA1 Protein, mhc1b Protein, major histocompatibility complex, class I, B Protein, major histocompatibility complex nonclassical class Ib L homeolog Protein, HLA-B Protein, BOLA-B Protein, MAMU-B18 Protein, DKFZP469N1225 Protein, mhc1b.L Protein
- Sujet
- MHC-B, HLA-B, HLAB, AS, SPDA1, Leukocyte Antigen B, Ankylosing Spondylitis, HLA class I histocompatibility antigen, B-7 alpha chain
- Poids moléculaire
- 37kDa
- UniProt
- P01889
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-